EXTON,
Pa., Feb. 1, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that it will release fourth-quarter and full-year 2023
financial results before the market opens on Thursday, February 15, 2024, and will follow with
a conference call to discuss the results and business expectations
at 9:00 a.m. Eastern Time.
The live audio-only webcast will be made available via the
Company's Investor Relations website here or by clicking here.
To participate in the conference call by asking questions to
Management, please register in advance by clicking here. Upon
registration, all telephone participants will receive the dial-in
number along with a unique PIN number that will be used to access
the call.
Management will refer to a slide presentation during the call,
which will be made available on the day of the call. To view the
presentation, select "Presentations" in the "Investors" section of
the Company's website. A replay of the conference call and webcast
will be available on the Company's website for 30 days.
A live audio webcast will be available in the "Investors"
section of the Company's website at www.westpharma.com. Replay of
the webcasts will be available for approximately 90 days after the
events.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With 10,000
team members across 50 sites worldwide, West helps support our
customers by delivering approximately 47 billion components and
devices each year.
In 2023, West commemorated a century of groundbreaking
innovation that has shaped the landscape of healthcare and impacted
the lives of patients around the world. This milestone served as a
testament to West's commitment to revolutionize drug delivery and
enhance the overall patient experience. Headquartered in
Exton, Pennsylvania, West in its
fiscal year 2022 generated $2.89
billion in net sales. West is traded on the New York Stock
Exchange (NYSE: WST) and is included on the Standard & Poor's
500 index. For more information, visit www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States
and other jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-to-host-fourth-quarter-and-full-year-2023-conference-call-302049723.html
SOURCE West Pharmaceutical Services, Inc.
